DOI:
10.1055/s-00000146
Diabetes aktuell
LinksClose Window
References
Bode BW, Buse JB, Fisher M. et al
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial.
Diabet Med 2013;
30: 1293-1297 doi:10.1111/dme
We do not assume any responsibility for the contents of the web pages of other providers.